Market Value244,210,000
Total Holdings51
File Date2022-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GH / Guardant Health, Inc.
STTK / Shattuck Labs, Inc.
MMM / 3M Company
DOMA / Doma Holdings Inc.
AVPT / AvePoint, Inc.
SKIL / Skillsoft Corp.
AVAH / Aveanna Healthcare Holdings Inc.
SPNT.PRB / SiriusPoint Ltd. - Preferred Stock
KZR / Kezar Life Sciences, Inc.
EOLS / Evolus, Inc.
CASA / Casa Systems, Inc.
HZNP / Horizon Therapeutics Plc
SKIN / The Beauty Health Company
TCDA / Tricida Inc
BHVN / Biohaven Ltd.
BLU / Bellus Health Inc
ACET / Adicet Bio, Inc.
ADV / Advantage Solutions Inc.
ITCI / Intra-Cellular Therapies, Inc.
RVMD / Revolution Medicines, Inc.
RIG / Transocean Ltd.
JAZZ / Jazz Pharmaceuticals plc
NKTR / Nektar Therapeutics
EW / Edwards Lifesciences Corporation
LLY / Eli Lilly and Company
ALGS / Aligos Therapeutics, Inc.
CCXI / ChemoCentryx Inc
MKFG / Markforged Holding Corporation
GNW / Genworth Financial, Inc.
FATE / Fate Therapeutics, Inc.
SKLZ / Skillz Inc.
ALLO / Allogene Therapeutics, Inc.
LSAQ / LifeSci Acquisition II Corp
CVM / CEL-SCI Corporation
LEV / The Lion Electric Company
ME / 23andMe Holding Co.
LPTX / Leap Therapeutics, Inc.
NLY / Annaly Capital Management, Inc.
UP / Wheels Up Experience Inc.
UWMC / UWM Holdings Corporation
BMY / Bristol-Myers Squibb Company
INBX / Inhibrx Biosciences, Inc.
GATO / Gatos Silver, Inc.
EXEL / Exelixis, Inc.
ALLK / Allakos Inc.
TVTX / Travere Therapeutics, Inc.
INSG / Inseego Corp.
XENE / Xenon Pharmaceuticals Inc.
EVH / Evolent Health, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
XFOR / X4 Pharmaceuticals, Inc.
NG / NovaGold Resources Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
PTGX / Protagonist Therapeutics, Inc.
ALDX / Aldeyra Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
CTLT / Catalent, Inc.
PTGX / Protagonist Therapeutics, Inc. Call
ARGX / argenx SE - Depositary Receipt (Common Stock)
RXDX / Prometheus Biosciences Inc
CHRS / Coherus Oncology, Inc.
CLDX / Celldex Therapeutics, Inc.
ALT / Altimmune, Inc.
INSP / Inspire Medical Systems, Inc.
STVN / Stevanato Group S.p.A.
FEMY / Femasys Inc.